BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34481868)

  • 1. Clotrimazole presents anticancer properties against a mouse melanoma model acting as a PI3K inhibitor and inducing repolarization of tumor-associated macrophages.
    Ochioni AC; Imbroisi Filho R; Esteves AM; Leandro JGB; Demaria TM; do Nascimento Júnior JX; Pereira-Dutra FS; Bozza PT; Sola-Penna M; Zancan P
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166263. PubMed ID: 34481868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clotrimazole reverses macrophage M2 polarization by disrupting the PI3K/AKT/mTOR pathway.
    Nascimento Júnior JXD; Sola-Penna M; Zancan P
    Biochem Biophys Res Commun; 2024 Feb; 696():149455. PubMed ID: 38176247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codonopsis pilosula polysaccharide in synergy with dacarbazine inhibits mouse melanoma by repolarizing M2-like tumor-associated macrophages into M1-like tumor-associated macrophages.
    Liu H; Amakye WK; Ren J
    Biomed Pharmacother; 2021 Oct; 142():112016. PubMed ID: 34385100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
    Locatelli SL; Careddu G; Serio S; Consonni FM; Maeda A; Viswanadha S; Vakkalanka S; Castagna L; Santoro A; Allavena P; Sica A; Carlo-Stella C
    Clin Cancer Res; 2019 Feb; 25(3):1098-1112. PubMed ID: 30352904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8
    Sun P; Zhang X; Wang RJ; Ma QY; Xu L; Wang Y; Liao HP; Wang HL; Hu LD; Kong X; Ding J; Meng LH
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34373258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
    Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
    Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway.
    Jang H; Ojha U; Jeong JH; Park KG; Lee SY; Lee YM
    Arch Pharm Res; 2023 Jul; 46(7):629-645. PubMed ID: 37468765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
    Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
    Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
    Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
    J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
    PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway.
    Chen J; Tang Y; Qin D; Yu X; Tong H; Tang C; Tang Z
    J Transl Med; 2023 Dec; 21(1):923. PubMed ID: 38124204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole.
    Furtado CM; Marcondes MC; Carvalho RS; Sola-Penna M; Zancan P
    Int J Biochem Cell Biol; 2015 May; 62():132-41. PubMed ID: 25794423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3Kγδ inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model.
    Han MG; Jang BS; Kang MH; Na D; Kim IA
    Eur J Cancer; 2021 Nov; 157():450-463. PubMed ID: 34601286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-Bound Polysaccharides from
    Jędrzejewski T; Pawlikowska M; Sobocińska J; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):615-628. PubMed ID: 32559360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.
    Luo F; Li H; Ma W; Cao J; Chen Q; Lu F; Qiu M; Zhou P; Xia Z; Zeng K; Zhan J; Zhou T; Luo Q; Pan W; Zhang L; Lin C; Huang Y; Zhang L; Yang D; Zhao H
    Cell Mol Immunol; 2024 Jan; 21(1):60-79. PubMed ID: 38062129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
    Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
    Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
    Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
    Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.